EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Bio-Techne's Enterprise Value is $10,482 Mil.
Bio-Techne's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $266 Mil. Therefore, Bio-Techne's EV-to-EBIT for today is 39.44.
The historical rank and industry rank for Bio-Techne's EV-to-EBIT or its related term are showing as below:
TECH'
s EV-to-EBIT Range Over the Past 10 Years
Min: 12.97 Med: 38.25 Max: 137.55
Current: 39.44
During the past 13 years, the highest EV-to-EBIT of Bio-Techne was 137.55. The lowest was 12.97. And the median was 38.25.
TECH's EV-to-EBIT is ranked worse than 83.37% of 439
companies
in the Biotechnology industry
Industry Median: 8.77
vs TECH: 39.44
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Bio-Techne's Enterprise Value for the quarter that ended in Dec. 2023 was $12,545 Mil.
Bio-Techne's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $266 Mil. Bio-Techne's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 2.12%.
Bio-Techne EV-to-EBIT Historical Data
The historical data trend for Bio-Techne's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Bio-Techne Annual Data
Trend
Jun14
Jun15
Jun16
Jun17
Jun18
Jun19
Jun20
Jun21
Jun22
Jun23
EV-to-EBIT
61.68
34.89
109.40
43.66
37.50
Bio-Techne Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-EBIT
39.84
35.33
37.50
37.67
47.21
Competitive Comparison
For the Biotechnology subindustry, Bio-Techne's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Techne EV-to-EBIT Distribution
For the Biotechnology industry and Healthcare sector, Bio-Techne's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Bio-Techne's EV-to-EBIT falls into.
Bio-Techne EV-to-EBIT Calculation
Bio-Techne's EV-to-EBIT for today is calculated as:
Bio-Techne's current Enterprise Value is $10,482 Mil.
Bio-Techne's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $266 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Techne (NAS:TECH) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Bio-Techne's Enterprise Value for the quarter that ended in Dec. 2023 was $12,545 Mil.
Bio-Techne's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $266 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Techne EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Bio-Techne's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TECH has been successfully added to your 